Ying He, Xiaoci He, Haijiao Zhang, Jin Jin, Yang Liu, Kui Chi, Limei Tang
{"title":"外周动脉疾病患者死亡率的危险因素:一项综合分析","authors":"Ying He, Xiaoci He, Haijiao Zhang, Jin Jin, Yang Liu, Kui Chi, Limei Tang","doi":"10.1016/j.clinme.2025.100517","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>This study provides an umbrella review to assess the methodological quality, biases, and the reliability of evidence regarding the factors influencing mortality in individuals with peripheral artery disease (PAD). It also offers a consolidated overview of the identified risk factors.</p><p><strong>Methods: </strong>The review protocol was registered in PROSPERO (CRD42024615105) PubMed, Web of Science, the Cochrane Database of Systematic Reviews and Embase were used to search, covering the period from inception until September 2024. AMSTAR and GRADE were used to independently evaluate the methodological rigor and quality of the evidence.</p><p><strong>Results: </strong>The review identified a total of 29 risk factors, of which 17 were significantly associated with higher mortality risk, while 12 did not show a notable association. The majority of the evidence was rated as low or very low quality, with only three risk factors being classified as having moderate-quality evidence. Key findings indicated that comorbidities such as chronic kidney disease, diabetes, underweight status, atrial fibrillation and depression were major contributors to higher mortality risk. In contrast, obesity and statin use were identified as being linked to a reduced risk of mortality. Additionally, blood biomarkers, including N-terminal pro-B-type natriuretic peptide, high-sensitivity C-reactive protein (CRP), and high-sensitivity cardiac troponin T were identified as important predictors of mortality.</p><p><strong>Conclusion: </strong>Comorbid conditions are key factors contributing to elevated mortality among individuals with PAD, whereas obesity and statin use are linked to reduced mortality risk. Additionally, blood biomarkers offer valuable insights into assessing mortality risk within this patient group.</p>","PeriodicalId":10492,"journal":{"name":"Clinical Medicine","volume":" ","pages":"100517"},"PeriodicalIF":3.9000,"publicationDate":"2025-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Risk factors for mortality in patients with peripheral artery disease: an umbrella analysis.\",\"authors\":\"Ying He, Xiaoci He, Haijiao Zhang, Jin Jin, Yang Liu, Kui Chi, Limei Tang\",\"doi\":\"10.1016/j.clinme.2025.100517\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>This study provides an umbrella review to assess the methodological quality, biases, and the reliability of evidence regarding the factors influencing mortality in individuals with peripheral artery disease (PAD). It also offers a consolidated overview of the identified risk factors.</p><p><strong>Methods: </strong>The review protocol was registered in PROSPERO (CRD42024615105) PubMed, Web of Science, the Cochrane Database of Systematic Reviews and Embase were used to search, covering the period from inception until September 2024. AMSTAR and GRADE were used to independently evaluate the methodological rigor and quality of the evidence.</p><p><strong>Results: </strong>The review identified a total of 29 risk factors, of which 17 were significantly associated with higher mortality risk, while 12 did not show a notable association. The majority of the evidence was rated as low or very low quality, with only three risk factors being classified as having moderate-quality evidence. Key findings indicated that comorbidities such as chronic kidney disease, diabetes, underweight status, atrial fibrillation and depression were major contributors to higher mortality risk. In contrast, obesity and statin use were identified as being linked to a reduced risk of mortality. Additionally, blood biomarkers, including N-terminal pro-B-type natriuretic peptide, high-sensitivity C-reactive protein (CRP), and high-sensitivity cardiac troponin T were identified as important predictors of mortality.</p><p><strong>Conclusion: </strong>Comorbid conditions are key factors contributing to elevated mortality among individuals with PAD, whereas obesity and statin use are linked to reduced mortality risk. Additionally, blood biomarkers offer valuable insights into assessing mortality risk within this patient group.</p>\",\"PeriodicalId\":10492,\"journal\":{\"name\":\"Clinical Medicine\",\"volume\":\" \",\"pages\":\"100517\"},\"PeriodicalIF\":3.9000,\"publicationDate\":\"2025-09-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/j.clinme.2025.100517\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"MEDICINE, GENERAL & INTERNAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.clinme.2025.100517","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
摘要
背景:本研究对影响外周动脉疾病(PAD)患者死亡率因素的方法学质量、偏倚和证据可靠性进行了综述。它还提供了已确定的风险因素的综合概述。方法:本综述方案在PROSPERO (CRD42024615105) PubMed、Web of Science、Cochrane系统综述数据库和Embase中检索,检索时间为创刊至2024年9月。AMSTAR和GRADE用于独立评估方法的严谨性和证据的质量。结果:综述共确定了29个危险因素,其中17个与较高的死亡风险显著相关,12个无显著相关性。大多数证据被评为低质量或极低质量,只有三个风险因素被归类为中等质量证据。主要研究结果表明,慢性肾脏疾病、糖尿病、体重不足、心房颤动和抑郁等合并症是导致死亡风险增加的主要因素。相比之下,肥胖和他汀类药物的使用被认为与降低死亡风险有关。此外,血液生物标志物,包括n端前b型利钠肽、高敏c反应蛋白(CRP)和高敏心肌肌钙蛋白T被确定为死亡率的重要预测因子。结论:合并症是导致PAD患者死亡率升高的关键因素,而肥胖和他汀类药物的使用与死亡率降低有关。此外,血液生物标志物为评估该患者组的死亡风险提供了有价值的见解。
Risk factors for mortality in patients with peripheral artery disease: an umbrella analysis.
Background: This study provides an umbrella review to assess the methodological quality, biases, and the reliability of evidence regarding the factors influencing mortality in individuals with peripheral artery disease (PAD). It also offers a consolidated overview of the identified risk factors.
Methods: The review protocol was registered in PROSPERO (CRD42024615105) PubMed, Web of Science, the Cochrane Database of Systematic Reviews and Embase were used to search, covering the period from inception until September 2024. AMSTAR and GRADE were used to independently evaluate the methodological rigor and quality of the evidence.
Results: The review identified a total of 29 risk factors, of which 17 were significantly associated with higher mortality risk, while 12 did not show a notable association. The majority of the evidence was rated as low or very low quality, with only three risk factors being classified as having moderate-quality evidence. Key findings indicated that comorbidities such as chronic kidney disease, diabetes, underweight status, atrial fibrillation and depression were major contributors to higher mortality risk. In contrast, obesity and statin use were identified as being linked to a reduced risk of mortality. Additionally, blood biomarkers, including N-terminal pro-B-type natriuretic peptide, high-sensitivity C-reactive protein (CRP), and high-sensitivity cardiac troponin T were identified as important predictors of mortality.
Conclusion: Comorbid conditions are key factors contributing to elevated mortality among individuals with PAD, whereas obesity and statin use are linked to reduced mortality risk. Additionally, blood biomarkers offer valuable insights into assessing mortality risk within this patient group.
期刊介绍:
Clinical Medicine is aimed at practising physicians in the UK and overseas and has relevance to all those managing or working within the healthcare sector.
Available in print and online, the journal seeks to encourage high standards of medical care by promoting good clinical practice through original research, review and comment. The journal also includes a dedicated continuing medical education (CME) section in each issue. This presents the latest advances in a chosen specialty, with self-assessment questions at the end of each topic enabling CPD accreditation to be acquired.
ISSN: 1470-2118 E-ISSN: 1473-4893 Frequency: 6 issues per year